Evaluation of ischemia-modified albumin in the diagnosis and the clinical severity of COVID-19 in children.

导出 LinkOut

翻译打印收藏纠错

第一作者： Eda Karadağ,Öncel

第一单位： Department of Pediatric Infectious Diseases, University of Health Sciences, Tepecik Training and Research Hospital, İzmir.

作者： Eda Karadağ,Öncel ^[1] ; Ayşegül Elvan,Tüz ^[1] ; Yıldız Ekemen,Keleş ^[1] ; Aslıhan,Şahin ^[1] ; Gülnihan,Üstündağ ^[1] ; Selin,Taşar ^[1] ; Tuba Kansu,Altan ^[2] ; İnanç,Karakoyun ^[2] ; Banu,İşbilen Başok ^[2] ; Salim,Neşelioğlu ^[3] ; Ahu,Kara Aksay ^[1] ; Dilek,Yılmaz ^[1] ; Özcan,Erel ^[3]

作者单位： Department of Pediatric Infectious Diseases, University of Health Sciences, Tepecik Training and Research Hospital, İzmir. ^[1] Department of Medical Biochemistry Clinic, University of Health Sciences, Tepecik Training and Research Hospital, İzmir. ^[2] Department of Medical Biochemistry Clinic, Yıldırım Beyazıt University, Ankara City Hospital, Ankara. ^[3]

关键词 COVID-19 child clinical severity diagnosis ischemia-modified albumin

主题词人类(Humans);儿童(Child);血清白蛋白(Serum Albumin);病例对照研究(Case-Control Studies)

DOI 10.24953/turkjped.2022.232

PMID 37395962

发布时间 2023-07-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交